menu
    • menu

    Company profile for LegoChem Biosciences

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    LegoChem Biosciences is a biopharmaceutical company focusing on the development of next generation novel therapeutics utilizing its proprietary medicinal drug discovery technology LegoChemistry™. By utilizing 20 unique scaffolds with drug-likeness, we have expedited drug discovery period and have secured a strong pipeline over research areas with great unmet medical needs, including ADCs & antibiotics.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    LegoChem Bioscienceskorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    8-26 Munpyeongseo-ro Daedeok-gu Daejeon, 34302
    Telephone
    Telephone
    042-861-0688
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.legochembio.com/eng/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/legochem-biosciences-inc-
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sionna salvages AbbVie assets for assault on cystic fibrosis
    Sionna salvages AbbVie assets for assault on cystic fibrosis

    16 Jul 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/sionna-salvages-abbvie-assets-teeing-dual-combo-assault-cystic-fibrosis

    FIERCE BIOTECH
    16 Jul 2024
    Share Share
    Samsung Biologics partners with LegoChem for ADC development and manufacturing
    Samsung Biologics partners with LegoChem for ADC development and manufacturing

    07 Feb 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/samsung-biologics-partners-with-legochem-biosciences-for-adc-development-and-manufacturing-302055657.html

    PR NEWSWIRE
    07 Feb 2024
    Share Share
    LegoChem, riding ADC sugar rush, raises $411M from sweet maker
    LegoChem, riding ADC sugar rush, raises $411M from sweet maker

    16 Jan 2024

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/legochem-riding-adc-sugar-rush-raises-411m-confectionery-company

    Nick Paul Taylor FIERCE BIOTECH
    16 Jan 2024
    Share Share
    J&J jumps on ADC from LegoChem in deal that could pay out over $1 billion
    J&J jumps on ADC from LegoChem in deal that could pay out over $1 billion

    27 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231225841872/en

    BUSINESSWIRE
    27 Dec 2023
    Share Share
    LegoChem Biosciences Announces License Agreement for LCB84 Trop2-Targeted ADC
    LegoChem Biosciences Announces License Agreement for LCB84 Trop2-Targeted ADC

    25 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231225841872/en

    BUSINESSWIRE
    25 Dec 2023
    Share Share
    LegoChem Selects BostonGene as Genomic Partner for First-in-Human Trial
    LegoChem Selects BostonGene as Genomic Partner for First-in-Human Trial

    07 Nov 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231107922235/en

    BUSINESSWIRE
    07 Nov 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search